Northwest Biotherapeutics, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2010 | $-6.4M | $-6.4M | $41.0K | $2.0M |
| FY2011 | $-14.7M | $-14.8M | $49.0K | $8.4M |
| FY2012 | $-22.8M | $-22.8M | $31.0K | $3.2M |
| FY2013 | $-37.8M | $-37.8M | $-1.0K | $1.4M |
| FY2014 | $-54.6M | $-54.6M | — | $0 |
| FY2015 | $-78.6M | $-78.6M | — | $3.4M |
| FY2016 | $-55.7M | $-55.7M | — | $127.0K |
| FY2017 | $-36.5M | $-36.5M | — | $842.0K |
| FY2018 | $-34.6M | $-34.6M | — | — |
| FY2019 | $-31.9M | $-32.0M | $171.0K | — |
| FY2020 | $-32.1M | $-32.1M | — | — |
| FY2021 | $-38.3M | $-38.3M | — | — |
| FY2022 | $-52.8M | $-52.8M | — | — |
| FY2023 | $-53.6M | $-53.6M | — | $3.6M |
| FY2024 | $-57.0M | $-58.0M | $1.0M | — |
| FY2025 | $-44.8M | $-46.3M | $1.5M | — |